首页> European journal of radiology> The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.

导出 OA

翻译打印收藏纠错

第一作者： Jasmine,Shell

第一单位： Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States.

作者： Jasmine,Shell ^[1] ; Amit,Tirosh ^[2] ; Corina,Millo ^[3] ; Samira M,Sadowski ^[4] ; Yasmine,Assadipour ^[5] ; Patience,Green ^[1] ; Dhaval,Patel ^[1] ; Naris,Nilubol ^[1] ; Electron,Kebebew ^[6]

作者单位： Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States. ^[1] Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States; Neuroendocrine Tumors Service, Chaim Sheba Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Israel. Electronic address: amit.tirosh@nih.gov. ^[2] Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States; PET Imaging Center, National Institutes of Health Clinical Center, Bethesda, Maryland, United States. ^[3] Endocrine and Thoracic Surgery, University Hospitals of Geneva, Geneva, Switzerland. ^[4] Section of Endocrine Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, United States. ^[5] Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States; Department of Surgery, The George Washington University, School of Medicine and Health Sciences, Washington, District of Columbia, United States. ^[6]

关键词 (68)Ga-DOTATATE PET/CT von Hippel-Lindau